C07C 239/14
Having nitrogen atoms of hydroxylamino groups further bound to carbon atoms of
Official title: having nitrogen atoms of hydroxylamino groups further bound to carbon atoms of hydrocarbon radicals substituted by doubly-bound oxygen atoms
C07C239/14 (Having nitrogen atoms of hydroxylamino groups further bound to carbon atoms of) appears on 17 US grants and 14 published applications in this corpus.
Search patents in C07C- Granted patents
- 17
- Published applications
- 14
- Assignees
- 14
- Inventors
- 51
- Latest grant
- 8 Apr 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1992 | 1 | 0 |
| 1993 | 0 | 0 |
| 1994 | 0 | 0 |
| 1995 | 0 | 0 |
| 1996 | 0 | 0 |
| 1997 | 0 | 0 |
| 1998 | 0 | 0 |
| 1999 | 0 | 0 |
| 2000 | 0 | 0 |
| 2001 | 0 | 0 |
| 2002 | 1 | 1 |
| 2003 | 4 | 2 |
| 2004 | 1 | 0 |
| 2005 | 1 | 1 |
| 2006 | 1 | 1 |
| 2007 | 0 | 0 |
| 2008 | 1 | 0 |
| 2009 | 0 | 0 |
| 2010 | 0 | 1 |
| 2011 | 0 | 0 |
| 2012 | 0 | 0 |
| 2013 | 0 | 0 |
| 2014 | 0 | 0 |
| 2015 | 0 | 0 |
| 2016 | 1 | 0 |
| 2017 | 0 | 0 |
| 2018 | 0 | 2 |
| 2019 | 0 | 0 |
| 2020 | 0 | 1 |
| 2021 | 2 | 2 |
| 2022 | 2 | 0 |
| 2023 | 1 | 1 |
| 2024 | 0 | 0 |
| 2025 | 1 | 2 |
By publication year. Applications have been published since 2001.
Recent patents
- Affinity illudofulvene conjugates8 Apr 2025US 12,269,793 B2AF Chemicals, LLC
- Affinity illudofulvene conjugates28 Feb 2023US 11,591,295 B2AF Chemicals, LLC
- Hypocrellin derivative substituted both in a peri-position and in 2-position by amino, preparation method, and application thereof13 Sep 2022US 11,439,707 B2Technical Institute of Physics and Chemistry of the Chinese Academy of Sciences
- Compound used as autophagy regulator, and preparation method therefor and uses thereof3 May 2022US 11,319,303 B2Wigen Biomedicine Technology (Shanghai) Co., Ltd.
- Monosubstituted or polysubstituted amphiphilic hypocrellin derivative, and preparation method and application thereof26 Oct 2021US 11,154,548 B2Technical Institute of Physics and Chemistry of the Chinese Academy of Sciences
- Affinity illudofulvene conjugates25 Sep 2025US 2025/0296912 A1Illudent, Inc.
- Compounds and method of use thereof for treating bacterial diseases16 Jan 2025US 2025/0019341 A1Institute of Genetics and Developental Biology, Chinese Academy of Sciences
- Affinity illudofulvene conjugates6 Jul 2023US 2023/0212113 A1AF Chemicals, LLC
- Affinity illudofulvene conjugates27 May 2021US 2021/0155583 A1AF Chemicals, LLC
- Hypocrellin derivative substituted both in a peri-position and in 2-position by amino, preparation method, and application thereof20 May 2021US 2021/0145968 A1Technical Institute of Physics and Chemistry of the Chinese Academy of Sciences
Most cited
By later US patents
- Vinylogous hydroxamic acids and derivatives thereof as 5-lipoxygenase inhibitors25US 5,110,831 AThe Du Pont Merck Pharmaceutical Company · 1992
- Inhibitors of α4 mediated cell adhesion15US 6,521,666 B1Tanabe Seiyaku Co., Ltd. · 2003
- 4(3)substituted-4(3)-aminomethyl-(thio)pyran or piperidine derivatives (=gabapentin analogues), their preparation and their use in the treatment of neurological disorders14US 6,545,022 B1Pfizer Inc. · 2003
- 1-substituted-1-aminomethyl-cycloalkane derivatives (=gabapentin analogues), their preparation and their use in the treatment of neurological disorders12US 6,518,289 B1Pfizer Inc. · 2003
- Inhibitors of α4 mediated cell adhesion8US 6,855,843 B2Tanabe Seiyaku Co., Ltd. · 2005